generic speaker image
Claire de Oliveira, PhD - Canadian Partnership Against Cancer. Toronto, ON, CA

Claire de Oliveira, PhD Claire de Oliveira, PhD

Expert Lead, Cancer Economics | Canadian Partnership Against Cancer

Toronto, ON, CANADA

Claire de Oliveira's main areas of research include measurement of the economic burden and the assessment of value for money in cancer care

Media

Publications:

Documents:

Photos:

loading image loading image loading image

Videos:

Audio:

Social

Biography

Dr. Claire de Oliveira joined the Canadian Partnership Against Cancer as Expert Lead, Cancer Economics in 2016. In this role, she develops health economics expertise within the Partnership and supports efforts to deepen the capacity to quantify the burden of cancer and assess the economic impact of a coordinated, pan-Canadian approach to cancer control. She also works across cancer control initiatives to quantify efficiencies and support efforts to improve the sustainability of the cancer control system. Dr. de Oliveira is also a member of the Partnership’s Analytic Capacity Building Committee.

In addition to her work at the Partnership, Dr. de Oliveira is a health economist at the Centre for Addiction and Mental Health; an assistant professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto; and an adjunct scientist at the Institute for Clinical Evaluative Sciences. Her main areas of research include: the development of costing methodology, the measurement of the economic burden, and the assessment of value for money in cancer care.

Dr. de Oliveira holds membership with the Canadian Centre for Applied Research in Cancer Control and is one of the program leads for Health Technology Assessment. In addition, she is a collaborator at the Toronto Health Economics Technology Assessment Collaborative.

Dr. de Oliveira holds a Masters of Arts degree and a Doctorate degree in economics from McMaster University. She also holds a licentiate degree in economics from the University of Oporto in Portugal.

Areas of Expertise (6)

Health Economics Cancer Health Services Research Policy Mental Health Child Health

Education (2)

McMaster University: PhD, Economics 2008

McMaster University: MA, Economics 2004

Affiliations (4)

  • Canadian Centre for Applied Research in Cancer Control: Member
  • Canadian Centre for Applied Research in Cancer Control: Program Lead, Health Technology Assessment
  • Insititute for Health Policy, Management and Evaluation, University of Toronto: Assistant Professor
  • Institute for Clinical Evaluative Sciences: Adjunct Scientist

Articles (4)

Phase-specific and lifetime costs of cancer care in Ontario, Canada BMC Cancer

2016

Cancer is a major public health issue and represents a significant economic burden to health care systems worldwide. The objective of this analysis was to estimate phase-specific, 5-year and lifetime net costs for the 21 most prevalent cancer sites, and remaining tumour sites combined, in Ontario, Canada.

view more

Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study CMAJ Open

2013

Cancer incidence and treatment-related costs are rising in Canada. We estimated health care use and costs in the first year after diagnosis for patients with 7 common types of cancer in Ontario to examine temporal trends in patterns of care and costs...

view more

Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis CMAJ Open

2013

Investments in medical research can result in health improvements, reductions in health expenditures and secondary economic benefits. These “returns” have not been quantified in Canada. Our objective was to estimate the return on cardiovascular disease research funded by public or charitable organizations...

view more

Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study CMAJ Open

2013

The first year after cancer diagnosis is a period of intensive treatment and high cost. We sought to estimate costs for the 21 most common cancers in Ontario in the 3-month period before and the first year after diagnosis...

view more

Contact